Bionano Reports Second Quarter 2026 Results and Provides a Business Update
Bionano Genomics reported a 21% revenue increase to $8.2 million in Q2 2026, driven by a 31% surge in consumables sales and expanding clinical adoption of its optical genome mapping (OGM) technology. The company completed retirement of its secured convertible debentures, simplifying its financial profile. Key scientific publications and returning o…